Occupational Activity – Page 12

Trump’s Re-Election: A Mixed Bag for Biopharma with M&A Upsides and Vaccine Concerns

5 months ago talkbio0Tagged Acquisitions, Administration occupational activities, Biopharma, Independence, Inflation, mergers, Policy, Transplant Registry Unified Management Program, United States Food and Drug Administration, Vaccines

Trump Administration, Biopharma, Mergers and Acquisitions, Vaccine Policy, Robert F. Kennedy Jr., FDA Independence, Inflation Reduction Act

UnitedHealthcare CEO Brian Thompson Fatally Shot in Targeted Attack Outside New York City Hotel

5 months ago talkbio0Tagged Brian Thompson, cellular targeting, CEO, Hotel, investor, Killing, New York City, Shooting sensation quality, UnitedHealthcare

UnitedHealthcare, CEO Brian Thompson, targeted killing, New York City, hotel shooting, investor meeting

Alligator Bioscience Slashes 70% of Workforce Due to Financial Strains

5 months ago talkbio0Tagged Alligators, Biopharma, Bioscience, Capital, constraints, Financial Stress, Industry, Staff

Alligator Bioscience, staff cuts, capital constraints, biopharma industry, financial challenges

Alligator Bioscience Cuts 70% of Workforce to Address Financial Challenges and Refocus on Pancreatic Cancer Research

5 months ago talkbio0Tagged Alligators, Bioscience, cost-cutting, financial, Industry, Pancreatic carcinoma, research

Alligator Bioscience, layoffs, cost-cutting, pancreatic cancer research, financial constraints, biotech industry

Sanofi Invests €1 Billion in Beijing to Enhance Insulin Production Capacity

5 months ago talkbio0Tagged Beijing, Drug Industry, Insulin, Investments, production, sanofi

Sanofi, insulin production, Beijing, investment, pharmaceutical industry

Kronos Undergoes Major Restructuring: CEO Norbert Bischofberger Exits Amid 83% Workforce Reduction

5 months ago talkbio0Tagged Bischofberger, Industry, Kronos layoffs, Norbert, restructuring

Kronos layoffs, Norbert Bischofberger, biotech industry, workforce reduction, restructuring

Controversial Stanford Professor Jay Bhattacharya Nominated by Trump to Lead NIH Amid Criticism Over Pandemic Views

5 months ago talkbio0Tagged Administration occupational activities, Appointments, Bhattacharya, Controversial, COVID19 (disease), Critic, Jay, NIH Director Nomination, Pandemic Response, Professor, Public Health Research, Stanford University, Transplant Registry Unified Management Program

Jay Bhattacharya, NIH Director Nomination, COVID-19 Pandemic Response Critic, Stanford University Professor, Trump Administration, Public Health Research, Controversial Appointment

Alector Cuts 17% of Workforce Following Failure of AbbVie-Partnered Alzheimer’s Drug in Phase 2 Trial

5 months ago talkbio0Tagged AbbVie, Alector, Alzheimer 's disease, Failure (biologic function), Industry, Phase 2 trial

Alector, layoffs, AbbVie, Alzheimer’s disease, phase 2 trial failure, biotech industry

Navigating JPM Week 2024: Insights and Opportunities in Biopharma

5 months ago talkbio0Tagged Biopharma, deal-making, Industry, Investments, IPOs, JPM, M&A, Network, regulatory, trends qualifier

JPM Week 2024, Biopharma, Industry Insights, Networking, Deal-making, Investment, M&A, IPOs, Regulatory Trends

Halozyme Therapeutics Abandons $2.1 Billion Acquisition Bid for Evotec Due to Lack of Engagement

5 months ago talkbio0Tagged Acquisition, Evotec, Halozyme, Industry, Twice a day, Withdraw (activity)

Halozyme Therapeutics, Evotec, acquisition bid, withdrawal, lack of engagement, biotech industry